NCT01818063View on ClinicalTrials.gov

Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

April 25, 2013

Primary Completion Date

March 1, 2015

Study Completion Date

December 10, 2018

Conditions
Estrogen Receptor-negative Breast CancerHER2-negative Breast CancerProgesterone Receptor-negative Breast CancerStage II Breast CancerStage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast CancerTriple-negative Breast Cancer
Interventions
DRUG

Paclitaxel

Given IV

DRUG

Carboplatin

Given IV

DRUG

Doxorubicin

Given IV

DRUG

Cyclophosphamide

Given IV

DRUG

Veliparib

Given PO

Trial Locations (3)

19107

Thomas Jefferson University, Philadelphia

19611

Reading Hospital, Reading

20889

Walter Reed National Military Medical Center, Bethesda

All Listed Sponsors
collaborator

Susan G. Komen Breast Cancer Foundation

OTHER

lead

Sidney Kimmel Cancer Center at Thomas Jefferson University

OTHER

NCT01818063 - Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer | Biotech Hunter | Biotech Hunter